The European Commission had requested the committee consider new data on the drug that became available after it had adopted its positive opinion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback